Professor John Collinge (UCL Institute of Prion Diseases) calls the news of positive results in an animal trial of a new therapy for prion disease "encouraging”. His team has developed another potential treatment which is also based on antibodies that target a protein called PrP.
Read: New Scientist
Close
